Antithrombin III (Human) and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Antithrombin III (Human) and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antithrombin iii
Brand name: Thrombate III
Synonyms: Antithrombin
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antithrombin III (Human)-Insulin glargine, recombinant Subcutaneous
- Antithrombin III (Human)-Insulin glulisine
- Antithrombin III (Human)-Insulin Glulisine (Cartridges and Pens)
- Antithrombin III (Human)-Insulin Glulisine (Vials)
- Antithrombin III (Human)-Insulin glulisine Subcutaneous
- Antithrombin III (Human)-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Antithymocyte Globulin (Equine)
- Insulin glargine and lixisenatide Subcutaneous-Antithymocyte globulin rabbit Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Antitussive Hydrocodone and Homatropine
- Insulin glargine and lixisenatide Subcutaneous-Antivenin
- Insulin glargine and lixisenatide Subcutaneous-Antivenin (Crotalidae) polyvalent
- Insulin glargine and lixisenatide Subcutaneous-Antivenin (crotalidae) polyvalent immune fab Intravenous